Observational cohort of patients treated with stereotactic radiotherapy for Oligo LYMPh nOde and other soft tissue metastasiS; the OLYMPOS cohort
Suspended
- Conditions
- oligometastatic cancer
- Registration Number
- NL-OMON29672
- Lead Sponsor
- MC Utrecht
- Brief Summary
https://doi.org/10.1080/0284186X.2021.1955970
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 700
Inclusion Criteria
Patients are eligible when they meet the following criteria:
•Is referred for, or will receive, stereotactic radiotherapy of a soft tissue metastasis with a localization other than brain or lung.
•Informed consent – at least – for use of routinely collected clinical data for research purposes (including follow up data in other hospitals)
Exclusion Criteria
Patients are ineligible when they meet the following criteria:
•Age <18 years
•Mentally incompetent patients
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method progression free survival after SBRT
- Secondary Outcome Measures
Name Time Method Physician-reported toxicity (CTCAE), overall survival, time until start of systemic treatment, patient-reported Quality of Life